Permanent blindness after cyclosporine neurotoxicity in a kidney-pancreas transplant recipient

Clinical Neuropharmacology

Volumn 19, Issue 3, 1996, Pages 259-266

  Esterl Jr , Robert M ^a,c   Gupta, Navyash ^b   Garvin, Paul J ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Blindness; Cyclosporine; Kidney pancreas transplant; Neurotoxicity

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; BLINDNESS; CASE REPORT; DIABETIC NEPHROPATHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MALE; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

EID: 0029880893     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199619030-00008     Document Type: Article

References (48)

1. Walker RW, Brochstein JA. Neurologic complications of immunosuppressive agents. Neurol Clin 1988;6:261-78.
2. Rubin AM, Kang H. Cerebral blindness and encephalopathy with cyclosporine A toxicity. Neurology 1987;37:1072-6.
3. deGroen PC, Askamit AJ, Rakela J, Forbes GS, Krom RAF. Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med 1987;317:861-6.
4. Adams DH, Ponsford S, Gunson B, et al. Neurological complications following liver transplantation. Lancet 1987;1:949-951.
5. Atkinson K, Biggs J, Darveniza P, Boland J, Concannon A, Dodds A. Spinal cord and cerebellar-like syndromes associated with the use of cyclosporine in human recipients of allogeneic marrow transplants. Transplant Proc 1985;17:1673-5.
6. Berden JHM, Hoitsma HJ, Merx JL, Keyser A. Severe central nervous system toxicity associated with cyclosporin [Letter]. Lancet 1985;1:219-20.
7. Ghalie R, Fitzsimmons WE, Bennett D. Cortical blindness: a rare complication of cyclosporine therapy. Bone Marrow Transplant 1990;6:147-9.
8. Tollemar J, Ringden O, Ericzon BG, Tyden G. Cyclosporine A-associated central nervous system toxicity. N Engl J Med 1988;318:788-9.
9. Hoefnagels WAJ, Gerritsen EJA, Brouwer OF, Souverijn JHM. Cyclosporin encephalopathy associated with fat embolism induced by the drug's solvent. Lancet 1988;2:901.
10. Scheinman SJ, Reinitz ER, Petro G, Schwartz RA, Szmalc FS. Cyclosporine central neurotoxicity following renal transplantation. Transplantation 1990;49:215-16.
11. Noll RB, Kulkarni R. Complex visual hallucinations and cyclosporine. Arch Neurol 1984;41:329-30.
12. Katirji MB. Visual hallucinations and cyclosporine. Transplantation 1987;43:768-9.
13. Palestine AG, Nussenblatt RB, Chan CC. Side effects of systemic cyclosporine in patients not undergoing transplantation. Am J Med 1984;77:652-6.
14. Durrant S, Chipping PM, Palmer S, Gordon-Smith EC, Cyclosporine A, methylprednisolone, and convulsions. Lancet 1982;2:829-30.
15. Shah D, Rylance PB, Rogerson ME, Bewick M, Parson V. Generalized epileptic fits in renal transplant recipients given cyclosporine A. Br J Med 1984;289:1347-8.
16. Rubin AM. Transient cortical blindness and occipital seizures with cyclosporine toxicity. Transplantation 1989;47:572-3.
17. Boogaerts MA, Zachee P, Verwilghen RL. Cyclosporin, methylprednisolone, and convulsions. Lancet 1982;2:1216.
18. Joss DV, Barrett AJ, Kendra JR, Lucas CF, Desai S. Hypertension and convulsions in children receiving cyclosporine A. Lancet 1982;2:906.
19. Nordal KP, Talseth T, Dahl E, et al. Aluminum overload: a predisposing condition for epileptic seizures in renal-transplant patients treated with cyclosporine? Lancet 1985;1:153.
20. Thompson CB, June CH, Sullivan KM, Thomas ED. Association between cyclosporin neurotoxicity and hypomagnesemia. Lancet 1984;2:1116.
21. Powell-Jackson PR, Carmichael FJL, Calne RY, Williams R. Adult respiratory distress syndrome and convulsions associated with administration of cyclosporin in liver transplant recipients. Transplantation 1984;38:341.
22. Velu T, Debusscher L, Stryckmans PA. Cyclosporin associated fatal convulsions. Lancet 1985:1:219.
23. Sloane JP, Lwin KY, Gore ME. Disturbance of blood-brain barrier after bone marrow transplantation. Lancet 1985;1:280.
24. Beaman M, Parvin S, Veitch PS. Convulsions associated with cyclosporin A in renal transplant recipients. Br J Med 1985;290:139.
25. Atkinson K, Biggs J, Darveniza P, Boland J, Concannon A, Dodds A. Cyclosporin-associated central nervous system toxicity after allogeneic hone marrow transplantation. Transplantation 1984;38:34.
26. O'Sullivan DP. Convulsions associated with cyclosporin A [Letter]. Br J Med 1985;290:858.
27. Gross MLP, Pearson RM, Kennedy J, Moorhead JF, Sweny P. Rejection encephalopathy [Letter]. Lancet 1982;2:1217.
28. Labar B, Bogdanic V, Plavsic F, et al. Cyclsporin neurotoxicity in patients treated with allogeneic bone marrow transplantation. Biomed Pharmacother 1986;40:148-50.
29. Kennedy MS, Yee GC, Deeg HJ, Storb R, Thomas ED. Pharmacokinetics and toxicity of cyclosporine in marrow transplant patients. Transplant Proc 1983;15:2416-18.
30. Poison RJ, Powell-Jackson PR, Williams R. Convulsions associated with cyclosporine A in transplant recipients [Letter]. Br J Med 1985;290:1003.
31. June CH, Thompson CB, Kennedy MS, Nims J, Thomas ED. Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation. Transplantation 1985;39:620-4.
32. Gross MLP, Pearson RM, Sweny P, Moorhead JF. Convulsions associated with cyclosporin A in renal transplant recipients [Letter]. Br J Med 1985;290:555.
33. European Multicentre Trial Group. Cyclosporin in cadaver renal transplantation: one year follow-up of a multicentre trial. Lancet 1983;2:986-9.
34. Kahan BD, Flechner SM, Lorber MI, Golden D, Conley S, Van Buren CT. Complications of cyclosporin-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center from one to five years. Transplantation 1987;43:197-204.
35. Moss NG, Powell SL, Falk RJ. Intravenous cyclosporine activates afferent and efferent nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci USA 1985:82:8222-6.
36. Drosos AA, Skopouli FN, Galanopoulou VK, Kitridou RC, Moutsopoulos HM. Cyclosporine therapy in patients with Sjögren's syndrome: results at one year. Scand J Rheumatol 1986;61:246-9.
37. Klintmalm G, Sawe J. High dose methylprednisolone increases plasma cyclosporin levels in renal transplant recipients. Lancet 1984;2:731.
38. Loughran TP Jr, Deeg HJ, Dahlberg S, Kennedy MS, Storb R, Thomas ED. Incidence of hypertension after marrow transplantation among 112 patients randomized to either cyclosporine or methotrexate as graft-versus-host disease prophylaxis. Br J Haematol 1985;59:547-53.
39. Wilson SE, deGroen PC, Aksamit AJ, Wiesner RH, Garrity JA, Krom RAF. Cyclosporin A-induced reversible cortical blindness. J Clin Neuroophthalmol 1988;8:215-20.
40. Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation. N Engl J Med 1975;292:895-902.
41. June CH, Thompson CB, Kennedy MS, Loughran TP Jr, Deeg HJ. Correlation of hypomagnesemia with the onset of cyclosporine-associated hypertension in marrow recipients. Transplantation 1986;41:47-51.
42. Siegl H, Ryffel B. Effect of cyclosporin on renin-angiotensin-aldosterone system. Lancet 1982;2:1274.
43. Siegl H, Ryffel B, Petric R, et al. Cyclosporine, the renin-angiotensin-aldosterone system and renal adverse reactions. Transplant Proc 1983;15:2719.
44. Lucey MR, Kolars JC, Merion RM, Campbell DA, Aldrich M, Watkins PB. Cyclosporine toxicity at therapeutic blood levels and cytochrome P-450 111A. Lancet 1990;1:11-15.
45. Ringdon O. Cyclosporine A in allogenic bone marrow transplantation. Transplantation 1986;42:445-52.
46. Wilczek H, Ringdon O, Tyden G. Cyclosporine-associated central nervous system toxicity after renal transplantation. Transplantation 1985;39:110.
47. Sieg RE, Garcia EG. Complex visual hallucinations and cyclosporine neurotoxicity. Neurology 1991;41:1156.
48. Nemunaitis J, Deeg HJ, Yee GC. High cyclosporin levels after marrow transplantation associated with hypertriglyceridaemia. Lancet 1986;2:744-5.